Aegle Marmelos Fruit based extract for Mycobacterium tuberculosis

You are here

The Novel Technology:

 
An extract of Aegle marmelos (Bael) fruit with cytotoxic effect against Mycobacterium tuberculosis
 
Applications:
  • To use the extract as an anti-TB formulation
  • To develop potential lead molecules from the identified compounds for therapeutic use against Mycobacterium tuberculosis
Advantages:
  • Easy to obtain extract from natural source than a synthetic sources
  • Extraction time is less compared to other methods  
  • Efficient system helps in obtaining higher yield
Business Model:
 
Early stage technology. Proof of concept by fractionation yielded a pure compound and demonstrated that hexane extract showed activity against Mycobacterium tuberculosis.
 
Principal Investigator(s): Dr. Ajay Kumar, RGCB
 
Invention ID: CMP-009
 
IP Status: Patent Pending
 
Jurisdictions: India (IN) 
 
For more details, please write to: